Case Number:

IPR2016-01479

Case Type:

IPR

Status:

Final Written Decision

Petitioner:

Par Pharmaceutical, Inc.

Patent Owner:

Novartis AG

Patent Number:

9006224

Tech Center:

1600

1. Filed: July 22, 2016 00:00

   Coverage

   1. February 21, 2017

      Par Gets PTAB Review Of Afinitor Patent

      Days after rejecting a challenge from Roxane Laboratories to a patent related to Novartis' blockbuster cancer drug Afinitor, the Patent Trial and Appeal Board agreed recently to review the patent based on a challenge from another generic drugmaker, Par Pharmaceutical.

   ---

   Stay ahead of the curve

   In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

   
   

   • Search PTAB cases and full-text documents.
   • Download filings with the U.S. Patent & Trademark Office’s Patent Trial & Appeal Board.
   • Set up alerts on new cases, follow ongoing cases, track new decisions and so much more!

   TRY LAW360 FREE FOR SEVEN DAYS

   View the PTAB case documents

   Already a subscriber? Click here to login